According to a post on the FDA’s website, Cadrenal Therapeutics’ tecarfarin received orphan designation.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVKD:
Education
About Us
Working with TipRanks
Follow Us
